Fem-Dophilus®
For Women’s Internal Balance*
PRODUCT HIGHLIGHTS
-
- Oral Probiotic for Natural Vaginal Health*
- Clinically-Documented Benefits
- 20+ Years of Clinical Research
- Patented Lactobacilli: GR-1® and RC-14®
- Prevention Magazine: Top 10 Breakthrough '07
What does Fem-Dophilus® do?
fem-dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1® and RC-14® to colonize and protect the vaginal tract.* Clinical trials have shown that GR-1® and RC-14®: - Help to maintain or restore healthy vaginal flora that are important in maintaining vaginal health*
- Support the health of the urinary tract*
fem-dophilus® is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency. The probiotic strains in fem-dophilus® are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.* Keep Refrigerated Keep out of the reach of children.
|
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Suggested Usage
For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed or take as directed by your qualified health care consultant.
Other Ingredients
Dextrose anhydrate, potato starch, cellulose and magnesium stearate (vegetable source). Capsule consists of gelatin and titanium dioxide.
Contains: Dairy (casein, in trace amounts).
No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no peanuts/tree nuts.
Jarrow Formulas® puts the “PRO” in probiotics™
|
Reformulation: 01/01/2007 | Design Change: 01/01/2007 | Text Revision: 03/04/2011